Specifically, in induced pluripotent stem (iPS) cells, in embryonal stem cells (ESCs), and in SALL4+ cancers, the expression of SALL4 has been related to the hypo-methylation of its promoter [36]. The gene discussed is SALL4; the disease is cancer.